Skip to main content

Summary

Antibody-drug conjugates utilize the targetting potential of antibodies to improve the potential of cytostatic or cytocidal drugs. One such murine monoclonal antibody, CTM01 (mCTM0l), which recognizes an epitope on breast epithelial mucin, has potential for the treatment of breast and ovarian cancers. We examine in this paper the comparative properties of mCTM01 against a number of other anti-mucin antibodies. We then describe the humanization and high level re-expression of humanized CTM01 (hCTM0l), a process designed to avoid the immune response to administered murine antibodies in human patients and to produce sufficient material for clinical studies. We show that the humanized form has properties superior to mCTM01 in terms of binding affinity to antigen presented on tumour cells.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aboud-Pirak, E., Sergent, T., Otte-Slachmuylder, C, Abarca, J., Trouet, A, and Schneider, Y.-J., 1988, Binding and endocytosis of a monoclonal antibody to a high molecular weight human milk fat globule membrane-associated antigen by cultured MCF-7 breast carcinoma cells, Cancer Res., 48: 3188.

    PubMed  CAS  Google Scholar 

  • Adair, J.R., 1992, Engineering antibodies for therapy, Immunological Reviews, 130: 1.

    Article  Google Scholar 

  • Adair, J.R., Athwal, D.S., and Emtage, J.S., 1991, Humanised antibodies, WO91/09967.

    Google Scholar 

  • Angal, S., King, D.J., Bodmer, M.W., Turner, A., Lawson, A.D.G., Pedley, B., Roberts, G., and Adair, J.R., 1992, A single amino acid substitution abolishes the heterogeneity of a chimeric mouse/human (IgG4) antibody, Mol. Immunol, in press.

    Google Scholar 

  • Atherton, E., and Sheppard, R.C., 1989, RSolid Phase Synthesis: A practical ApproachS, IRL Press, Oxford.

    Google Scholar 

  • Baker, T.S., Begent, R.H.J., Dewji, M.R., Conlan, J., and Secher, D.S., 1991, Characterization of the antibody response in patients undergoing radioimmunotherapy with chimeric B72.3, Antibod. Immunoconj. Radiopharm., 4: 799.

    Google Scholar 

  • Bebbington, C.R., 1991, Expression of antibody genes in nonlymphoid mammalian cells, Methods, 2: 136.

    Article  CAS  Google Scholar 

  • Bebbington, C.R., Renner, G., Thomson, S., King, D., Abrams, D., and Yarranton, G.T., 1992, High-level expression of a recombinant antibody from myeloma cells using a Glutamine synthetase gene as an amplifiable selectable marker, Bio/Technology, 10: 169.

    Article  PubMed  CAS  Google Scholar 

  • Begent, R,H,J., Ledermann, J.A., Bagshawe, K.D., Green, A.J., Kelly, A.M.B., Lane, D., Secher, D.S., Dewji, M.R., and Baker, T.S., 1990, Phase I/II study of chimeric B72.3 antibody in radioimmunotherapy of colorectal carcinoma, Br. J. Cancer, 62: 487.

    Google Scholar 

  • Blank, E.W., Pant, K.D., Chan, C.M., Peterson, J.A., and Ceriani, R.L., 1992, A novel anti-breast mucin Mab (Bre-3). Characterization and experimental biodistribution and immunotherapy, Cancer J., 5: 38.

    CAS  Google Scholar 

  • Briggs, S., Price, M.R., and Tendler, S J.B., 1991, Immune recognition of linear peptides in peptide fragments of epithelial mucins, Immunology, 73: 505.

    PubMed  CAS  Google Scholar 

  • Burchell, H., Durbin, H., and Taylor-Papadimitriou, J., 1983, Complexity and expression of antigen determinants recognized by monoclonal antibodies HMFG1 and HMFG2 in normal and malignant human mammary epithelial cells, J. Immunol, 131: 508.

    PubMed  CAS  Google Scholar 

  • Burchell, H., Gendler, S., Taylor-Papadimitriou, J., Girling, A., Lewis, A., Millis, R., and Lamport, D., 1987, Development and characterisation of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin, Cancer Res., 47: 5476.

    PubMed  CAS  Google Scholar 

  • Carter P., Presta, L., Gorman, C.M., Ridgway, J.B.B., Henner, D., Wong, W.L.T., Rowland, A.M., Kotts, C, Carver, M.E., and Shepard, H.M., 1992, Humanization of an anti-p185HER2 antibody for human cancer therapy, Proc. Natl. Acad. Sci. USA, 89: 4285.

    Article  PubMed  CAS  Google Scholar 

  • Catane, R., and Longo, D.L., 1988, Monoclonal antibodies for cancer therapy. Isr. J. Med. Sci., 24: 471.

    PubMed  CAS  Google Scholar 

  • Ceriani, R.L., ed., 1991, RBreast Epithelial Antigens. Molecular Biology to Clinical Applications, Plenum Press, New York.

    Google Scholar 

  • Co. M.S., Avdalovic, N.M., Caron, PC, Avdalovic, M.V., Scheinberg, D.A., and Queen, C 1992, Chimeric and humanized antibodies with specificity for the CD33 antigen, J. Immunol., 148: 1149.

    PubMed  CAS  Google Scholar 

  • Co, M.S., Deschamps, M., Whitley, R.J., and Queen, C, 1991, Humanized antibodies for antiviral therapy, Proc. Natl. Acad. Sci. USA, 88: 2869.

    Article  PubMed  CAS  Google Scholar 

  • Cockett, M.I., Bebbington, C.R., and Yarranton, G.T., 1990, High-level expression of tissue inhibitor of metalloproteinases in Chinese hamster ovary cells using Glutamine synthetase gene amplification, Bio/Technology, 8: 662.

    Article  PubMed  CAS  Google Scholar 

  • Cockett, M.I., Bebbington, C.R., and Yarranton, G.T., 1991, The use of engineered El A genes to transactivate the hCMV-MIE promoter in permanent CHO cell lines, Nucl. Acids Res., 19: 319.

    Article  PubMed  CAS  Google Scholar 

  • Daugherty, B.L., DeMartino, J.A., Law, M.-E, Kawka, D.W., Singer, I.I., and Mark, G.E., 1991, Polymerase chain reaction facilitates the cloning, CDR-grafting and rapid expression of a murine monoclonal antibody directed against the CD 18 component of leukocyte integrins. Nucl. Acids Res., 19: 2471.

    Article  PubMed  CAS  Google Scholar 

  • DeNardo, S.J., Warhoe, K.A., OUGrady L.F., DeNardo, G.L., Hellstrom, I., Hellstrom, K.E., and Mills, S.L., 1991a, Radioimmunotherapy with I-131 chimeric L-6 in advanced breast cancer, in RBreast Epithelial Antigens. Molecular Biology to Clinical ApplicationsS. Ceriani, R. L., ed., Plenum Press, New York.

    Google Scholar 

  • DeNardo, S.J., Warhoe, K.A., OUGrady L.F., Gobuty, A.H., Macey, D.J., Hellstrom, I., Hellstrom, K.E., Kroger, L.E., and DeNardo, G.L., 1991b, I-131 Human-chimeric MoAB L6: Bionetics and radioimmunotherapy in patients with metastatic breast cancer, Antibod. Immunoconj. Immunother., 4: 34.

    Google Scholar 

  • Dion, A.S., Smordinsky, N.I., Williams, C.J., Wreschner, D.H., Major, P.P., and Keydov, I., 1991. Recognition of polypeptides by polymorphic epithelial mucin (PEM) specific monoclonal antibodies. Hybridoma, 10: 595.

    Article  PubMed  CAS  Google Scholar 

  • Drak, J., Iwasawa, N., Danishefsky, S., and Crothers, D.M., 1991. The carbohydrate domain of calicheamicin γ1 I determines its sequence specificity for DNA cleavage. Proc. Natl. Acad. Sci. USA, 88: 7464.

    Article  PubMed  CAS  Google Scholar 

  • Gendler, S.J., Burchell, J.M., Duhig, T, Lamport, D., White, R., Parker, M., and Taylor-Papadimitriou, J., 1987, Cloning of partial cDNA encoding differentiation and tumour associated mucin glycoproteins expressed by human mammary epithelium. Proc. Natl. Acad. Sci. USA, 84: 6060.

    Article  PubMed  CAS  Google Scholar 

  • Girling, A., Bartkova, J., Burchell, J., Gendler, S., Gillet, C, and Taylor-Papadimitriou, J., 1989, A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM3 is selectively exposed in a range of carcinomas, Int. J. Cancer, 43; 1072.

    Article  PubMed  CAS  Google Scholar 

  • Goodman, G., 1991, Phase I trial of chimeric monoclonal antibody L6: Comparisons to murine L6. 6th Annual Conference on Antibody Immunoconjugates and Radiopharmaceuticals. San Diego, USA.

    Google Scholar 

  • Hakimi, J., Chizzonite, R., Luke, D.R., Familletti, P.C, Bailon, P., Kondas, J.A., Pilson, R.S., Lin, P., Weber, D.V., Spence, C, Mondini, L.J., Tsien, W.-H., Levin, J.E., Gallati, V.H., Korn, L., Waldmann, T.A., Queen, C, and Benjamin, W.R., 1991, Reduced immunogenicity and improved pharmacokinetics of humanized anti-Tac in cynomolgus monkeys, J. Immunol., 147; 1352.

    PubMed  CAS  Google Scholar 

  • Hale, G., Dyer, M.J., Clark, M.R., Phillips, J.M., Marcus, R., Riechmann, L., Winter, G., and Waldmann, H., 1988, Remission induction in Non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H, Lancet, ii:1394.

    Article  Google Scholar 

  • Hilkens, J., Buijs, E, and Ligtenberg, M., 1989, Complexity of Mam-6, an epithelial sialomucin associated with carcinomas, Cancer Res., 49: 786.

    PubMed  CAS  Google Scholar 

  • Hilkens, J., Ligtenberg, M.J.L., Vos, H.L., and Litvinov, S.V., 1992, Cell membrane-asociated mucins and their adhesion-modulating properties. Trends in Biochemical Sciences, 17: 359.

    Article  PubMed  CAS  Google Scholar 

  • Hinman, L.M., Wallace, R.E., Hamann, P.E., Durr, F.E., and Upeslacis, J. 1991, Calicheamicin immunoconjugates:inluence of analog and linker modification on activity in vivo, Antibody Immunoconjugates and Radipharmaceuticals, 3:59.

    Google Scholar 

  • Isaacs, J.D., Watts, R.A., Hazleman, B.L., Hale, G., Keogan, M.T., Cobbold, S.P., and Waldmann, H., 1992, Humanised antibody therapy for rheumatoid arthritis, Lancet, 340: 748.

    Article  PubMed  CAS  Google Scholar 

  • Kelley, R.F., OUConnell, M.P Carter, P., Presta, L., Eigenbrot, C, Covarrubias, M., Snedcor, B., Bourell, J.H., and Vetterlein, D., 1992, Antigen binding thermodynamics and anti-proliferative effects of chimeric and humanized anti-p185HER2 antibody Fab fragments, Biochemistry, 31: 5434.

    Article  PubMed  CAS  Google Scholar 

  • Keydar, J., Chou, C.S., Hareuveni, M., Tsarfaty, I., Sahar, E., Selzer, G., Chaitchik, S., and Hizi, A., 1989, Production and characterisation of monoclonal antibodies identifying breast tumour associated antigens, Proc. Natl. Acad. Sci. USA, 86: 1362.

    Article  PubMed  CAS  Google Scholar 

  • Khazaeli, M.B., Saleh, M.N., Liu, T.P., Meredith, R.F., Wheeler, R.H., Baker, T.S., King, D., Secher, D., Allen, L., Rogers, K., Colcher, D., Schlom, J., Shochat. T,D., and LoBuglio, A.F., 1991, Pharmacokinetics and immune response of 131I-chimeric mouse/human B72.3 (human gamma 4) monoclonal antibody in man, Cancer Res., 51: 5461.

    PubMed  CAS  Google Scholar 

  • King, D.J., Adair, J.R., Angal, S., Low, D.C., Proudfoot, K.A., Lloyd, J.C., Bodmer, M., and Yarranton, G.T., 1992, Expression, purification and characterisation of a mouse: human chimeric antibody and chimeric FabU fragment Biochem. J., 281: 317.

    PubMed  CAS  Google Scholar 

  • Knox, S J., Levy, R., Hodgkinson, S., Bell, R., Brown, S., Wood, G.S., Hoppe, R., Abel, E.A., Steinman, L., Berger, R.G., Gaiser, C, Young, G., Bindl, J., Hanham, A., and Reichert, T,., 1991, Observations on the effect of chimeric anti-CD4 monoclonal antibody in patients with Mycosis Fungoides, Blood, 77: 20.

    PubMed  CAS  Google Scholar 

  • Kabat, E.A., Wu, T.T., Reid-Miller, M., Perry, H.M. and Gottesman, K.S., 1987, Sequences of Proteins of Immunological Interest, 4th edition. United States Department of Health and Human Services, Washington DC.

    Google Scholar 

  • Layton, G.T., Devine, P.L., Warren, J.A., Birrell, G., Xing, P.-X., Ward, B.G., and McKenzie, I.F.C., 1990, Monoclonal antibodies reactive with the breast carcinoma-associated mucin core repeat sequence peptide also recognise the ovarian carcinoma-associated sebaceous gland-antigen, Tumor Biol, 11: 274.

    Article  CAS  Google Scholar 

  • Lee, M.D., Dunne, T.S., Siegel, M.M., Chang, C.C., Morton, G.O. and Borders, D.B., 1987a, Calicheamicins, a novel family of antitumor antibiotics. 1. Chemistry and partial structure of calicheamicin γ 1 I, J. Am. Chem. Soc, 109: 3464.

    Article  CAS  Google Scholar 

  • Lee, M.D., Dunne, T.S., Chang, C.C., Ellestad, G.A., Siegel, M.M., Morton, G.O., McGahren, W.J. and Borders, D.B., 1987b, Calicheamicins, a novel family of antitumor antibiotics. 2. Chemistry and solution structure of calicheamicin γ 1 I, J. Am. Chem. Soc, 109: 3466.

    Article  CAS  Google Scholar 

  • Lewis, A.P., and Crowe, J.S., 1991, Immunoglobulin complementarity determining region grafting by recombinant polymerase chain reaction to generate humanised monoclonal antibodies, Gene, 101: 297.

    Article  PubMed  CAS  Google Scholar 

  • Ligtenberg, M.J., Vos, H.L., Gennissen, A.M., and Hilkens, J., 1990. Episialin, a carcinoma associated mucin, is generated by a polymorphic gene encoding splice variants with alternative amino termini, J. Biol. Chem., 265: 5573.

    PubMed  CAS  Google Scholar 

  • LoBuglio, A.R, Wheeler, R.H., Trang, J., Haynes, A., Rogers, K., Harvey, E.B., Sun, L. Ghrayeb, J., and Khazaeli, M.B., 1989. Mouse/human chimeric monoclonal antibody in man: Kinetics and immune response, Proc. Natl Acad. Sci USA, 86: 4220.

    Article  PubMed  CAS  Google Scholar 

  • LoBuglio, A.R, Meredith, R., Wheeler, R.H., Rogers, K.J., Liu, T, Allen, L., Polansky, A., Plott, G., and Khazaeli, M.B., 1991, Chimeric monoclonal antibody studies in colo-rectal cancer. in RMonoclonal Antibodies Applications in Clinical OncologyS Epenetos, A. A., ed., Chapman and Hall Medical, London.

    Google Scholar 

  • Mathieson, P.W, Cobbold, S.D., Hale, G., Clark, M.R., Oliveira, D.B., Lockwood, CM., and Waldmann, H., 1990. Monoclonal antibody therapy in systemic vasculitis. New Engl. J. Med., 323: 250.

    Article  PubMed  CAS  Google Scholar 

  • Meredith, R.F., Khazaeli, M.B., Plott, W.E., Saleh, M.N., Liu, T., Allen, L.F., Russell, C.D., Orr, R.A., Colcher, D., Schlom, J., Shochat, D., Wheeler, R.W., and LoBuglio, A.F., 1992b, Phase I trial of Iodine-131-chimeric B72.3 (human IgG4) in metastatic colorectal cancer, J. Nucl. Med., 33: 23.

    PubMed  CAS  Google Scholar 

  • Meredith, R.F., LoBuglio, A.R, Plott, W.E., Orr, R.A., Brezovich, I.A., Russell, C.D., Harvey, E.B., Yester, M.V., Wagner, A.J., Spencer, S.A., Wheeler, R.H., Saleh, M.N., Rogers, K.J., Polansky, A., Salter, M.M., and Khazaeli, M.B., 1991, Pharmacokinetics, immune response, and biodistribution of Iodine-131-labeled chimeric mouse/human IgG1,κ 17-1 A monoclonal antibody, J. Nucl Med., 32: 1162.

    PubMed  CAS  Google Scholar 

  • Meredith, R.F., Khazaeli, M.B., Plott, W.E., Brezovich, I.A., Russell, C.D., Wheeler, R.H., Spencer, S.A., and LoBuglio, A.R, 1992a, Comparison of two mouse/human chimeric antibodies in patients with metastatic colon cancer, Antibod. Immunoconj. Radiopharm., 5: 75.

    Google Scholar 

  • Morrison, S.L., Johnson, M J., Herzenberg, L.A., and Oi, V.T., 1984, Chimeric human antibody molecules: Mouse antigen-binding domains with human constant region domains. Proc. Natl Acad. Sci. USA., 81: 6851.

    Article  PubMed  CAS  Google Scholar 

  • Nicolaou, K.C., Dai, W.-M., Tsav, S.-C, Estevez, V.A., and Wrasidlo, W, 1992, Designed enedienes: a new class of DNA-cleaving molecules with potent and selective anticancer activity, Science, 256: 1172.

    Article  PubMed  CAS  Google Scholar 

  • Price, M.R., Clarke, A.J., Robertson, J.F.R., OUSullivan, C, Baldwin, R.W and Blarney, R.W, 1990a, Detection of polymorphic epithelial mucins in the presence in the serum of systemic breast cancer patients using the monoclonal antibody NCRC-11, Cancer Immunol Immunother., 31: 269.

    Article  PubMed  CAS  Google Scholar 

  • Price, M.R., Crocker, G., Edwards, S., Nagra, C.S., Robins, R.A., Williams, M., Blarney, R.W, Swalow, D.M., and Baldwin, R.W, 1987, Identification of a monoclonal antibody-defined breast carcinoma antigen in body fluids, Eur. J. Cancer Clin. Oncol, 23: 1169.

    Article  PubMed  CAS  Google Scholar 

  • Price, M.R., Hudecz, R, OUSullivan, C, Baldwin, R.W Edwards, P.M., and Tendler, S.J.B., 1990b, Immunological and structural features of the protein core of human polymorphic epithelial mucin, Mol. Immunol, 27: 795.

    Article  PubMed  CAS  Google Scholar 

  • Price, M.R., Pugh, J.A., Hudecz, R, Griffiths, W., Jacobs, E., Symonds, I.M., Clarke, A.J., Chan, W.C, and Baldwin, R.W, 1990c, C595-a monoclonal antibody against the protein core of human urinary epithelial mucin commonly expressed in breast carcinomas, Br. J. Cancer, 61: 681.

    Article  PubMed  CAS  Google Scholar 

  • Queen, C, Schneider, W.P., Selick, H.E., Payne, P.W., Landolfi, N.F., Duncan, J.F., Avdalovic, N.M., Levitt, M., Junghans, R.P., and Waldmann, T.A., 1989, A humanized antibody that binds to the interleukin 2 receptor, Proc. Natl. Acad. Sci. USA., 86: 10029.

    Article  PubMed  CAS  Google Scholar 

  • Saiki, R.K., Gelfand, D.H., Stoffel, S., Scharf, S.F, Higuchi, R., Horn, R.T., Mullis, K.B., and Ehrlich, H.A., 1988, Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase, Science, 239: 487.

    Article  PubMed  CAS  Google Scholar 

  • Saleh, M.N., Khazaeli, M.B., Wheeler, R.H., Allen, L., Tilden, A.B., Grizzle, W., Reisfeld, R.A., Yu, A.L., Gillies, S.D., and LoBuglio, A.F., 1992, Phase I trial of the chimeric anti-GD2 monoclonal antibody chl4.18 in patients with malignant melanoma, Hum. Antibod. Hybridomas, 3: 19.

    CAS  Google Scholar 

  • Sekine, H., Ohno, T., and Kufe, D.W., 1985, Purification and characterization of high molecular weight glycoprotein detected in human milk and human carcinoma, J. Immunol., 135: 3610.

    PubMed  CAS  Google Scholar 

  • Soule, H.D., Albert, S., Brennan, M., Vazquez, J., and Long, A., 1973. A human cell line froma pleural effusion derived from a breats carcinoma J. Natl Cancer Inst., 51: 1409.

    PubMed  CAS  Google Scholar 

  • Stephens, P.E., and Cockett, M.I., 1989, The construction of a highly efficient and versatile set of mammalian expression vectors, Nucl. Acids Res., 17: 7110.

    Article  PubMed  CAS  Google Scholar 

  • Taylor-Papadimitriou, J., Peterson, J.A., Arklie, J., Burchell, J., Ceriani, R.L., and Bodmer, W.F., 1981, Monoclonal antibodies to epithelium specific components of human milkfat globule membrane:productin and reaction with cells in culture, Int. J. Cancer, 28: 17.

    Article  PubMed  CAS  Google Scholar 

  • Toneguzzo, F, Hayday, A.C., and Keating, A., 1986, Electric field mediated DNA transfer: transient and stable gene expression in human and mouse lymphoid cells, Mol. Cell Biol, 6: 703.

    PubMed  CAS  Google Scholar 

  • Trang, J.M., LoBuglio, A.F., Wheeler, R.H., Harvey, E.B., Sun, L., Ghrayeb, J., and Khazaeli,6M.B., 1990, Pharmacokinetics of a mouse/human chimeric monoclonal antibody (C-17-1 A) in metastatic adenocarcinoma patients. Pharmacol. Res., 1: 587.

    Google Scholar 

  • Van Dam, P.A., Lowe, D.G., Watson, J.V., Jobling, T.W., Chard, X, and Shepard, J.H., 1991. Multiparameter flow cytometric quantitation of the expression of the tumour associated antigen SM3 in normal and neoplastic ovarian tissue. Cancer, 68: 169.

    Article  PubMed  Google Scholar 

  • Wreschner, D.H., Hareuveni, M., Tsarfaty, I., Smorodinsky, N., Horev, J., Zaretsky, J., Kotkes, P., Weiss, M., Lathe, R., Dion, A and Keydar, I., 1990. Human epithelial tumour antigen cDNA sequences. Eur. J. Biochem., 189: 463.

    Article  PubMed  CAS  Google Scholar 

  • Wreschner, D.H., Tsarfaty, L, Hareuveni, M., Zaretsky, J., Smorodinsky, N., Weiss, M., Zrihan, S., Burstein, M., Horev, J., Kotkes, P., Lathe, R., Hart, C.A., McCarthy, K., Williams, C, Dion, A., and Keydar, I., 1991, Molecular analysis of H23 epithelial antigen-differentially spliced full length cDNAs and gene, in RBreast Epithelial Antigens. Molecular Biology to Clinical ApplicationsS Ceriani, R.L., ed., Plenum Press, New York.

    Google Scholar 

  • Wu, T.T., and Kabat, E.A., 1970, An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity, J. Exp. Med., 132: 211.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media New York

About this chapter

Cite this chapter

Baker, T.S. et al. (1994). Humanization of an Anti-Mucin Antibody for Breast and Ovarian Cancer Therapy. In: Ceriani, R.L. (eds) Antigen and Antibody Molecular Engineering in Breast Cancer Diagnosis and Treatment. Advances in Experimental Medicine and Biology, vol 353. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2443-4_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-2443-4_8

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6038-4

  • Online ISBN: 978-1-4615-2443-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics